Potential role of imaging markers in predicting future disease expression of arrhythmogenic cardiomyopathy

Future Cardiol. 2021 Jul;17(4):647-654. doi: 10.2217/fca-2020-0107. Epub 2020 Oct 21.

Abstract

Aim: To evaluate the predictive accuracy of trabecular hypertrophy/derangement and late gadolinium enhancement in predicting diagnosis of arrhythmogenic cardiomyopathy (AC). Materials & methods: Fifty-nine suspected AC patients were evaluated. To evaluate the ability of these markers to detect patients fulfilling definite diagnosis at 4-year follow-up, sensitivity (Se), specificity (Sp), positive and negative predictive value (PPV and NPV) and predictive accuracy (PA) were calculated. Results: Presence of trabecular hypertrophy/derangement showed high NPV, while late gadolinium enhancement at cardiac MRI high Sp, NPV and PA. Their combination with symptoms and/or revised Task Force Criteria showed a high Sp, NPV and PA for definitive diagnosis during follow-up. Conclusion: In suspected AC patients, the absence of these markers allows to identify those with lower risk of disease progression.

Keywords: arrhythmogenic cardiomyopathy; diagnosis; late gadolinium enhancement; red flags; trabecular hypertrophy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiomyopathies* / diagnostic imaging
  • Contrast Media*
  • Gadolinium
  • Humans
  • Magnetic Resonance Imaging
  • Predictive Value of Tests

Substances

  • Contrast Media
  • Gadolinium